BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 24684569)

  • 1. Testosterone therapy and cancer risk.
    Eisenberg ML; Li S; Betts P; Herder D; Lamb DJ; Lipshultz LI
    BJU Int; 2015 Feb; 115(2):317-21. PubMed ID: 24684569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testosterone therapy and the risk of cardiovascular disease in older, hypogonadal men.
    Krishnan S; Aldana-Bitar J; Golub I; Ichikawa K; Shabir A; Bagheri M; Hamidi H; Benzing T; Kianoush S; Budoff MJ
    Prog Cardiovasc Dis; 2024; 84():14-18. PubMed ID: 38423237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do we have enough evidences that make you safe to treat a man with hypogonadism one year after a radical prostatectomy for prostate cancer? | Opinion: Not Yet.
    Wroclawski ML; Heldwein FL
    Int Braz J Urol; 2018; 44(1):8-13. PubMed ID: 29424507
    [No Abstract]   [Full Text] [Related]  

  • 4. Do we have enough evidences that make you safe to treat a man with hypogonadism one year after a radical prostatectomy for prostate cancer? | Opinion: YES.
    Torres LO
    Int Braz J Urol; 2018; 44(1):4-7. PubMed ID: 29424506
    [No Abstract]   [Full Text] [Related]  

  • 5. Testosterone therapy and cancer risks among men in the SEER-Medicare linked database.
    Butler EN; Zhou CK; Curry M; McMenamin Ú; Cardwell C; Bradley MC; Graubard BI; Cook MB
    Br J Cancer; 2023 Jan; 128(1):48-56. PubMed ID: 36307648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Misinterpretation of the Comparative Safety of Testosterone Dosage Forms-Reply.
    Layton JB; Stürmer T; Brookhart MA
    JAMA Intern Med; 2015 Nov; 175(11):1875-6. PubMed ID: 26524762
    [No Abstract]   [Full Text] [Related]  

  • 7. Guidelines for testosterone therapy for men: how to avoid a mad (t)ea party by getting personal.
    Anawalt BD
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2614-7. PubMed ID: 20525909
    [No Abstract]   [Full Text] [Related]  

  • 8. Testosterone Replacement Therapy and Prostate Cancer Incidence.
    Eisenberg ML
    World J Mens Health; 2015 Dec; 33(3):125-9. PubMed ID: 26770932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long vs Short Acting Testosterone Treatments: A Look at the Risks.
    Gurayah AA; Dullea A; Weber A; Masterson JM; Khodamoradi K; Mohamed AI; Ramasamy R
    Urology; 2023 Feb; 172():5-12. PubMed ID: 36455678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant medication? Testosterone and cancer.
    Pastuszak AW
    BJU Int; 2015 Feb; 115(2):179-80. PubMed ID: 25604717
    [No Abstract]   [Full Text] [Related]  

  • 11. Incidence of prostate cancer in hypogonadal men receiving testosterone therapy: observations from 5-year median followup of 3 registries.
    Haider A; Zitzmann M; Doros G; Isbarn H; Hammerer P; Yassin A
    J Urol; 2015 Jan; 193(1):80-6. PubMed ID: 24980615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone therapy and prostate cancer--safety concerns are well founded.
    Klotz L
    Nat Rev Urol; 2015 Jan; 12(1):48-54. PubMed ID: 25563848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbidity of type 1 diabetes and juvenile idiopathic arthritis.
    Hermann G; Thon A; Mönkemöller K; Lilienthal E; Klinkert C; Holder M; Hörtenhuber T; Vogel-Gerlicher P; Haberland H; Schebek M; Holl RW; ;
    J Pediatr; 2015 Apr; 166(4):930-5.e1-3. PubMed ID: 25641245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and prevalence of juvenile chronic arthritis in East Berlin 1980-88.
    Kiessling U; Döring E; Listing J; Meincke J; Schöntube M; Strangfeld A; Zink A
    J Rheumatol; 1998 Sep; 25(9):1837-43. PubMed ID: 9733469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MECHANISMS IN ENDOCRINOLOGY: Medical consequences of doping with anabolic androgenic steroids: effects on reproductive functions.
    Nieschlag E; Vorona E
    Eur J Endocrinol; 2015 Aug; 173(2):R47-58. PubMed ID: 25805894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of adipocytokine levels and vascular functions in young aged to middle aged men with idiopathic hypogonadotrophic hypogonadism.
    Tuna MM; Doğan BA; Karakılıç E; Arduç A; Işık S; Yılmaz FM; Topçuoğlu C; Berker D; Güler S
    Neuro Endocrinol Lett; 2014; 35(7):640-4. PubMed ID: 25617889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The epidemiologic data on falls, 1998-2010: more older Americans report falling.
    Cigolle CT; Ha J; Min LC; Lee PG; Gure TR; Alexander NB; Blaum CS
    JAMA Intern Med; 2015 Mar; 175(3):443-5. PubMed ID: 25599461
    [No Abstract]   [Full Text] [Related]  

  • 18. Testosterone levels and bone mineral density in healthy elderly men.
    Moran JM; Lavado-García JM; Roncero-Martin R; Pedrera-Canal M; Vera V; Fernandez P; Pedrera-Zamorano JD
    J Am Geriatr Soc; 2015 Jan; 63(1):206-7. PubMed ID: 25597589
    [No Abstract]   [Full Text] [Related]  

  • 19. Longitudinal association between habitual walking and fall occurrences among community-dwelling older adults: analyzing the different risks of falling.
    Okubo Y; Seino S; Yabushita N; Osuka Y; Jung S; Nemoto M; Figueroa R; Tanaka K
    Arch Gerontol Geriatr; 2015; 60(1):45-51. PubMed ID: 25456885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How are falls and fear of falling associated with objectively measured physical activity in a cohort of community-dwelling older men?
    Jefferis BJ; Iliffe S; Kendrick D; Kerse N; Trost S; Lennon LT; Ash S; Sartini C; Morris RW; Wannamethee SG; Whincup PH
    BMC Geriatr; 2014 Oct; 14():114. PubMed ID: 25348492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.